Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06370039
PHASE2

Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease

Sponsor: Invirsa, Inc.

View on ClinicalTrials.gov

Summary

Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during 4-week repeat dosing in subjects with moderate to severe dry eye disease.

Official title: Phase 2, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study of INV-102 Ophthalmic Solution in Adult Subjects With Moderate to Severe Dry Eye Disease

Key Details

Gender

All

Age Range

18 Years - 74 Years

Study Type

INTERVENTIONAL

Enrollment

109

Start Date

2024-03-27

Completion Date

2024-07-03

Last Updated

2026-09-18

Healthy Volunteers

No

Conditions

Interventions

DRUG

INV-102

INV-102 Ophthalmic Solution

DRUG

Vehicle

Vehicle Ophthalmic Solution

Locations (1)

iuvo BioScience

Rush, New York, United States